baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

NeoGenomics Inc/ US64049M2098 /

2024-04-25 10:00:00 PM	Chg. -0.1800	Volume	Bid1:47:12 PM	Ask1:47:12 PM	High	Low
13.8500USD	-1.28%	792,553 Turnover: 6.82 mill.	12.1900Bid Size: 100	14.5300Ask Size: 100	14.0000	13.5500

GlobeNewswire 03-28 ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights

GlobeNewswire 01-30 Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

GlobeNewswire 01-26 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc...

GlobeNewswire 01-18 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc...

GlobeNewswire 01-10 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc...

GlobeNewswire 01-02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc...

GlobeNewswire 2023-12-20 ACELYRIN, INC. Appoints Lynn Tetrault to Board of Directors

Newsfile Corp 2023-11-14 Kudos Announces the 39 2023 Best Culture Award Winners: Celebrating Excellence in Workplace Culture

GlobeNewswire 2022-03-29 NEO Shareholder News: Johnson Fistel Encourages NeoGenomics Shareholders with Losses to Contact the ...

GlobeNewswire 2022-03-17 Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung C...

GlobeNewswire 2022-03-14 Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary

GlobeNewswire 2022-02-11 Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR™ in Head...

GlobeNewswire 2022-01-11 Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX ...

GlobeNewswire 2021-11-30 Genetron Health Reports Third Quarter 2021 Unaudited Financial Results

GlobeNewswire 2021-11-08 Genetron Health Establishes Strategic Partnership with NeoGenomics to Drive Global Oncology Drug Res...

GlobeNewswire 2021-11-04 Akoya Biosciences to Present Data at SITC 2021 Highlighting Novel Spatial Biology Applications

GlobeNewswire 2021-10-19 Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liq...

GlobeNewswire 2021-09-09 Inivata and collaborators to present data that further validate the application of its RaDaR™ MRD an...

GlobeNewswire 2021-05-25 Inivata Announces Collaboration with F-star Therapeutics for the use of RaDaRTM Assay

GlobeNewswire 2021-05-05 Inivata to be Acquired by NeoGenomics

GlobeNewswire 2021-04-28 Inivata and Agendia Sign Agreement for Commercialization of RaDaR® MRD Liquid Biopsy Assay in Breast...

GlobeNewswire 2021-04-10 Inivata Presents New Data in Support of its Liquid Biopsy Technologies at AACR Virtual Annual Meetin...

GlobeNewswire 2021-03-17 Inivata to Present New Data in Support of its RaDaR™ MRD and InVisionFirst®-Lung tests at AACR Virtu...

GlobeNewswire 2021-03-09 FDA Grants Breakthrough Device Designation for Inivata’s RaDaR™ Assay

GlobeNewswire 2021-02-04 Parexel and NeoGenomics Announce Strategic Collaboration in Precision Medicine to Improve Study Desi...

NeoGenomics Inc/ US64049M2098 /

If you wish to receive reply to your feedback, please provide your email address.